nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.1	0.172	CbGbCtD
Trabectedin—CYP2C19—Progesterone—uterine cancer	0.08	0.137	CbGbCtD
Trabectedin—PTGS1—Etoposide—uterine cancer	0.074	0.127	CbGbCtD
Trabectedin—CYP2C9—Progesterone—uterine cancer	0.0665	0.114	CbGbCtD
Trabectedin—CYP2D6—Progesterone—uterine cancer	0.0609	0.104	CbGbCtD
Trabectedin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0584	0.1	CbGbCtD
Trabectedin—CYP2E1—Etoposide—uterine cancer	0.0571	0.0979	CbGbCtD
Trabectedin—CYP3A4—Progesterone—uterine cancer	0.0387	0.0663	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—uterine cancer	0.0186	0.0318	CbGbCtD
Trabectedin—CYP3A4—Etoposide—uterine cancer	0.0173	0.0297	CbGbCtD
Trabectedin—CYP3A4—Doxorubicin—uterine cancer	0.0118	0.0202	CbGbCtD
Trabectedin—SRC—artery—uterine cancer	0.00655	0.149	CbGeAlD
Trabectedin—PTGS1—oviduct—uterine cancer	0.00369	0.084	CbGeAlD
Trabectedin—SRC—epithelium—uterine cancer	0.00248	0.0565	CbGeAlD
Trabectedin—SRC—uterine cervix—uterine cancer	0.00246	0.056	CbGeAlD
Trabectedin—PTGS1—artery—uterine cancer	0.00245	0.0556	CbGeAlD
Trabectedin—SRC—smooth muscle tissue—uterine cancer	0.00239	0.0545	CbGeAlD
Trabectedin—SRC—decidua—uterine cancer	0.00235	0.0534	CbGeAlD
Trabectedin—SRC—renal system—uterine cancer	0.0023	0.0524	CbGeAlD
Trabectedin—SRC—female reproductive system—uterine cancer	0.00185	0.042	CbGeAlD
Trabectedin—SRC—female gonad—uterine cancer	0.00168	0.0382	CbGeAlD
Trabectedin—SRC—lymph node—uterine cancer	0.00108	0.0246	CbGeAlD
Trabectedin—PTGS1—epithelium—uterine cancer	0.000927	0.0211	CbGeAlD
Trabectedin—PTGS1—uterine cervix—uterine cancer	0.000919	0.0209	CbGeAlD
Trabectedin—PTGS1—smooth muscle tissue—uterine cancer	0.000894	0.0203	CbGeAlD
Trabectedin—CYP2E1—renal system—uterine cancer	0.000893	0.0203	CbGeAlD
Trabectedin—CYP2C19—vagina—uterine cancer	0.00088	0.02	CbGeAlD
Trabectedin—PTGS1—renal system—uterine cancer	0.00086	0.0196	CbGeAlD
Trabectedin—PTGS1—endometrium—uterine cancer	0.000832	0.0189	CbGeAlD
Trabectedin—PTGS1—mammalian vulva—uterine cancer	0.000804	0.0183	CbGeAlD
Trabectedin—PTGS1—uterus—uterine cancer	0.000766	0.0174	CbGeAlD
Trabectedin—CYP2C9—female reproductive system—uterine cancer	0.000755	0.0172	CbGeAlD
Trabectedin—CYP3A4—renal system—uterine cancer	0.000718	0.0163	CbGeAlD
Trabectedin—CYP2E1—female reproductive system—uterine cancer	0.000715	0.0163	CbGeAlD
Trabectedin—CYP2D6—renal system—uterine cancer	0.000707	0.0161	CbGeAlD
Trabectedin—PTGS1—female reproductive system—uterine cancer	0.000689	0.0157	CbGeAlD
Trabectedin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.00252	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.000633	0.00251	CcSEcCtD
Trabectedin—Liver injury—Doxorubicin—uterine cancer	0.000633	0.00251	CcSEcCtD
Trabectedin—Dyspepsia—Progesterone—uterine cancer	0.000631	0.0025	CcSEcCtD
Trabectedin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000631	0.0025	CcSEcCtD
Trabectedin—Alopecia—Dactinomycin—uterine cancer	0.00063	0.0025	CcSEcCtD
Trabectedin—PTGS1—female gonad—uterine cancer	0.000627	0.0143	CbGeAlD
Trabectedin—PTGS1—vagina—uterine cancer	0.000623	0.0142	CbGeAlD
Trabectedin—Decreased appetite—Progesterone—uterine cancer	0.000623	0.00247	CcSEcCtD
Trabectedin—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000619	0.00246	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Progesterone—uterine cancer	0.000619	0.00246	CcSEcCtD
Trabectedin—Fatigue—Progesterone—uterine cancer	0.000618	0.00245	CcSEcCtD
Trabectedin—Constipation—Progesterone—uterine cancer	0.000613	0.00243	CcSEcCtD
Trabectedin—Pancytopenia—Etoposide—uterine cancer	0.000612	0.00243	CcSEcCtD
Trabectedin—Extravasation—Doxorubicin—uterine cancer	0.000611	0.00243	CcSEcCtD
Trabectedin—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000607	0.00241	CcSEcCtD
Trabectedin—Neutropenia—Etoposide—uterine cancer	0.000603	0.00239	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000591	0.00235	CcSEcCtD
Trabectedin—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000587	0.00233	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.000586	0.00233	CcSEcCtD
Trabectedin—Gastrointestinal pain—Progesterone—uterine cancer	0.000586	0.00233	CcSEcCtD
Trabectedin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000583	0.00231	CcSEcCtD
Trabectedin—Musculoskeletal pain—Epirubicin—uterine cancer	0.000583	0.00231	CcSEcCtD
Trabectedin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000579	0.0023	CcSEcCtD
Trabectedin—Pulmonary embolism—Epirubicin—uterine cancer	0.000576	0.00229	CcSEcCtD
Trabectedin—CYP3A4—female reproductive system—uterine cancer	0.000575	0.0131	CbGeAlD
Trabectedin—Infestation NOS—Etoposide—uterine cancer	0.000575	0.00228	CcSEcCtD
Trabectedin—Infestation—Etoposide—uterine cancer	0.000575	0.00228	CcSEcCtD
Trabectedin—Anaemia—Dactinomycin—uterine cancer	0.000573	0.00228	CcSEcCtD
Trabectedin—Injection site reaction—Epirubicin—uterine cancer	0.000572	0.00227	CcSEcCtD
Trabectedin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000571	0.00227	CcSEcCtD
Trabectedin—Abdominal pain—Progesterone—uterine cancer	0.000566	0.00225	CcSEcCtD
Trabectedin—Body temperature increased—Progesterone—uterine cancer	0.000566	0.00225	CcSEcCtD
Trabectedin—CYP2D6—female reproductive system—uterine cancer	0.000566	0.0129	CbGeAlD
Trabectedin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000564	0.00224	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00056	0.00223	CcSEcCtD
Trabectedin—Stomatitis—Etoposide—uterine cancer	0.00056	0.00222	CcSEcCtD
Trabectedin—Jaundice—Etoposide—uterine cancer	0.00056	0.00222	CcSEcCtD
Trabectedin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00056	0.00222	CcSEcCtD
Trabectedin—Leukopenia—Dactinomycin—uterine cancer	0.000555	0.00221	CcSEcCtD
Trabectedin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000555	0.0022	CcSEcCtD
Trabectedin—Hepatobiliary disease—Etoposide—uterine cancer	0.000543	0.00216	CcSEcCtD
Trabectedin—Musculoskeletal pain—Doxorubicin—uterine cancer	0.000539	0.00214	CcSEcCtD
Trabectedin—Agranulocytosis—Etoposide—uterine cancer	0.000536	0.00213	CcSEcCtD
Trabectedin—Pulmonary embolism—Doxorubicin—uterine cancer	0.000533	0.00212	CcSEcCtD
Trabectedin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000531	0.00211	CcSEcCtD
Trabectedin—Injection site reaction—Doxorubicin—uterine cancer	0.00053	0.0021	CcSEcCtD
Trabectedin—Myalgia—Dactinomycin—uterine cancer	0.000528	0.0021	CcSEcCtD
Trabectedin—Hypersensitivity—Progesterone—uterine cancer	0.000528	0.0021	CcSEcCtD
Trabectedin—CYP2D6—female gonad—uterine cancer	0.000515	0.0117	CbGeAlD
Trabectedin—Asthenia—Progesterone—uterine cancer	0.000514	0.00204	CcSEcCtD
Trabectedin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000513	0.00204	CcSEcCtD
Trabectedin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000513	0.00204	CcSEcCtD
Trabectedin—Pulmonary oedema—Epirubicin—uterine cancer	0.000513	0.00204	CcSEcCtD
Trabectedin—Oedema—Dactinomycin—uterine cancer	0.000506	0.00201	CcSEcCtD
Trabectedin—Infection—Dactinomycin—uterine cancer	0.000503	0.002	CcSEcCtD
Trabectedin—Sepsis—Epirubicin—uterine cancer	0.0005	0.00198	CcSEcCtD
Trabectedin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000496	0.00197	CcSEcCtD
Trabectedin—Diarrhoea—Progesterone—uterine cancer	0.00049	0.00195	CcSEcCtD
Trabectedin—Anorexia—Dactinomycin—uterine cancer	0.000483	0.00192	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000481	0.00191	CcSEcCtD
Trabectedin—Flushing—Etoposide—uterine cancer	0.000479	0.0019	CcSEcCtD
Trabectedin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000478	0.0019	CcSEcCtD
Trabectedin—Pulmonary oedema—Doxorubicin—uterine cancer	0.000474	0.00188	CcSEcCtD
Trabectedin—Dizziness—Progesterone—uterine cancer	0.000474	0.00188	CcSEcCtD
Trabectedin—Angiopathy—Etoposide—uterine cancer	0.000468	0.00186	CcSEcCtD
Trabectedin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000466	0.00185	CcSEcCtD
Trabectedin—Hepatic failure—Epirubicin—uterine cancer	0.000465	0.00185	CcSEcCtD
Trabectedin—Mediastinal disorder—Etoposide—uterine cancer	0.000465	0.00185	CcSEcCtD
Trabectedin—Sepsis—Doxorubicin—uterine cancer	0.000462	0.00184	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000461	0.00183	CcSEcCtD
Trabectedin—Alopecia—Etoposide—uterine cancer	0.000456	0.00181	CcSEcCtD
Trabectedin—Vomiting—Progesterone—uterine cancer	0.000456	0.00181	CcSEcCtD
Trabectedin—Rash—Progesterone—uterine cancer	0.000452	0.00179	CcSEcCtD
Trabectedin—Dermatitis—Progesterone—uterine cancer	0.000451	0.00179	CcSEcCtD
Trabectedin—Headache—Progesterone—uterine cancer	0.000449	0.00178	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000445	0.00177	CcSEcCtD
Trabectedin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000444	0.00176	CcSEcCtD
Trabectedin—Decreased appetite—Dactinomycin—uterine cancer	0.00044	0.00175	CcSEcCtD
Trabectedin—Dysgeusia—Etoposide—uterine cancer	0.00044	0.00175	CcSEcCtD
Trabectedin—Fatigue—Dactinomycin—uterine cancer	0.000437	0.00173	CcSEcCtD
Trabectedin—Back pain—Etoposide—uterine cancer	0.000434	0.00172	CcSEcCtD
Trabectedin—Hepatic failure—Doxorubicin—uterine cancer	0.00043	0.00171	CcSEcCtD
Trabectedin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000429	0.0017	CcSEcCtD
Trabectedin—Nausea—Progesterone—uterine cancer	0.000426	0.00169	CcSEcCtD
Trabectedin—Anaemia—Etoposide—uterine cancer	0.000415	0.00165	CcSEcCtD
Trabectedin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000414	0.00164	CcSEcCtD
Trabectedin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000413	0.00164	CcSEcCtD
Trabectedin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000409	0.00163	CcSEcCtD
Trabectedin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000409	0.00162	CcSEcCtD
Trabectedin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000407	0.00162	CcSEcCtD
Trabectedin—PTGS1—lymph node—uterine cancer	0.000403	0.00917	CbGeAlD
Trabectedin—Leukopenia—Etoposide—uterine cancer	0.000402	0.0016	CcSEcCtD
Trabectedin—Abdominal pain—Dactinomycin—uterine cancer	0.0004	0.00159	CcSEcCtD
Trabectedin—Body temperature increased—Dactinomycin—uterine cancer	0.0004	0.00159	CcSEcCtD
Trabectedin—Loss of consciousness—Etoposide—uterine cancer	0.000395	0.00157	CcSEcCtD
Trabectedin—Cough—Etoposide—uterine cancer	0.000392	0.00156	CcSEcCtD
Trabectedin—Blood creatinine increased—Epirubicin—uterine cancer	0.000392	0.00156	CcSEcCtD
Trabectedin—Dehydration—Epirubicin—uterine cancer	0.000389	0.00154	CcSEcCtD
Trabectedin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000386	0.00153	CcSEcCtD
Trabectedin—Abdominal pain upper—Epirubicin—uterine cancer	0.000382	0.00152	CcSEcCtD
Trabectedin—Hypokalaemia—Epirubicin—uterine cancer	0.00038	0.00151	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00038	0.00151	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000376	0.00149	CcSEcCtD
Trabectedin—Hypersensitivity—Dactinomycin—uterine cancer	0.000373	0.00148	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000369	0.00146	CcSEcCtD
Trabectedin—Infection—Etoposide—uterine cancer	0.000364	0.00145	CcSEcCtD
Trabectedin—Asthenia—Dactinomycin—uterine cancer	0.000363	0.00144	CcSEcCtD
Trabectedin—Blood creatinine increased—Doxorubicin—uterine cancer	0.000362	0.00144	CcSEcCtD
Trabectedin—Dehydration—Doxorubicin—uterine cancer	0.00036	0.00143	CcSEcCtD
Trabectedin—Thrombocytopenia—Etoposide—uterine cancer	0.000359	0.00143	CcSEcCtD
Trabectedin—Skin disorder—Etoposide—uterine cancer	0.000356	0.00141	CcSEcCtD
Trabectedin—Abdominal pain upper—Doxorubicin—uterine cancer	0.000353	0.0014	CcSEcCtD
Trabectedin—Hypokalaemia—Doxorubicin—uterine cancer	0.000352	0.0014	CcSEcCtD
Trabectedin—Anorexia—Etoposide—uterine cancer	0.000349	0.00139	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000348	0.00138	CcSEcCtD
Trabectedin—Diarrhoea—Dactinomycin—uterine cancer	0.000346	0.00138	CcSEcCtD
Trabectedin—Pancytopenia—Epirubicin—uterine cancer	0.000343	0.00136	CcSEcCtD
Trabectedin—Hypotension—Etoposide—uterine cancer	0.000342	0.00136	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000341	0.00135	CcSEcCtD
Trabectedin—Neutropenia—Epirubicin—uterine cancer	0.000338	0.00134	CcSEcCtD
Trabectedin—Paraesthesia—Etoposide—uterine cancer	0.000329	0.00131	CcSEcCtD
Trabectedin—Weight decreased—Epirubicin—uterine cancer	0.000327	0.0013	CcSEcCtD
Trabectedin—Dyspnoea—Etoposide—uterine cancer	0.000327	0.0013	CcSEcCtD
Trabectedin—Infestation NOS—Epirubicin—uterine cancer	0.000322	0.00128	CcSEcCtD
Trabectedin—Infestation—Epirubicin—uterine cancer	0.000322	0.00128	CcSEcCtD
Trabectedin—Vomiting—Dactinomycin—uterine cancer	0.000322	0.00128	CcSEcCtD
Trabectedin—Rash—Dactinomycin—uterine cancer	0.000319	0.00127	CcSEcCtD
Trabectedin—Decreased appetite—Etoposide—uterine cancer	0.000319	0.00127	CcSEcCtD
Trabectedin—Pancytopenia—Doxorubicin—uterine cancer	0.000317	0.00126	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000316	0.00126	CcSEcCtD
Trabectedin—Fatigue—Etoposide—uterine cancer	0.000316	0.00125	CcSEcCtD
Trabectedin—Jaundice—Epirubicin—uterine cancer	0.000314	0.00125	CcSEcCtD
Trabectedin—Stomatitis—Epirubicin—uterine cancer	0.000314	0.00125	CcSEcCtD
Trabectedin—Constipation—Etoposide—uterine cancer	0.000313	0.00124	CcSEcCtD
Trabectedin—Neutropenia—Doxorubicin—uterine cancer	0.000313	0.00124	CcSEcCtD
Trabectedin—Hepatobiliary disease—Epirubicin—uterine cancer	0.000305	0.00121	CcSEcCtD
Trabectedin—Weight decreased—Doxorubicin—uterine cancer	0.000302	0.0012	CcSEcCtD
Trabectedin—Nausea—Dactinomycin—uterine cancer	0.000301	0.00119	CcSEcCtD
Trabectedin—Agranulocytosis—Epirubicin—uterine cancer	0.000301	0.00119	CcSEcCtD
Trabectedin—Gastrointestinal pain—Etoposide—uterine cancer	0.0003	0.00119	CcSEcCtD
Trabectedin—Infestation NOS—Doxorubicin—uterine cancer	0.000298	0.00118	CcSEcCtD
Trabectedin—Infestation—Doxorubicin—uterine cancer	0.000298	0.00118	CcSEcCtD
Trabectedin—Haemoglobin—Epirubicin—uterine cancer	0.000291	0.00115	CcSEcCtD
Trabectedin—Stomatitis—Doxorubicin—uterine cancer	0.000291	0.00115	CcSEcCtD
Trabectedin—Jaundice—Doxorubicin—uterine cancer	0.000291	0.00115	CcSEcCtD
Trabectedin—Abdominal pain—Etoposide—uterine cancer	0.00029	0.00115	CcSEcCtD
Trabectedin—Body temperature increased—Etoposide—uterine cancer	0.00029	0.00115	CcSEcCtD
Trabectedin—Haemorrhage—Epirubicin—uterine cancer	0.000289	0.00115	CcSEcCtD
Trabectedin—Oedema peripheral—Epirubicin—uterine cancer	0.000285	0.00113	CcSEcCtD
Trabectedin—Connective tissue disorder—Epirubicin—uterine cancer	0.000284	0.00113	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000282	0.00112	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—uterine cancer	0.000278	0.0011	CcSEcCtD
Trabectedin—Hypersensitivity—Etoposide—uterine cancer	0.00027	0.00107	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—uterine cancer	0.000269	0.00107	CcSEcCtD
Trabectedin—Flushing—Epirubicin—uterine cancer	0.000268	0.00107	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—uterine cancer	0.000268	0.00106	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—uterine cancer	0.000264	0.00105	CcSEcCtD
Trabectedin—Asthenia—Etoposide—uterine cancer	0.000263	0.00104	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—uterine cancer	0.000263	0.00104	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—uterine cancer	0.000262	0.00104	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—uterine cancer	0.000261	0.00103	CcSEcCtD
Trabectedin—Alopecia—Epirubicin—uterine cancer	0.000256	0.00101	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—uterine cancer	0.000253	0.00101	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—uterine cancer	0.000252	0.001	CcSEcCtD
Trabectedin—Diarrhoea—Etoposide—uterine cancer	0.000251	0.000996	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—uterine cancer	0.000248	0.000986	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—uterine cancer	0.000247	0.000979	CcSEcCtD
Trabectedin—Back pain—Epirubicin—uterine cancer	0.000243	0.000967	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—uterine cancer	0.000243	0.000964	CcSEcCtD
Trabectedin—Dizziness—Etoposide—uterine cancer	0.000242	0.000962	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—uterine cancer	0.000241	0.000958	CcSEcCtD
Trabectedin—Alopecia—Doxorubicin—uterine cancer	0.000236	0.000939	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—uterine cancer	0.000234	0.000931	CcSEcCtD
Trabectedin—Vomiting—Etoposide—uterine cancer	0.000233	0.000925	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—uterine cancer	0.000233	0.000925	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—uterine cancer	0.000233	0.000924	CcSEcCtD
Trabectedin—Rash—Etoposide—uterine cancer	0.000231	0.000918	CcSEcCtD
Trabectedin—Dermatitis—Etoposide—uterine cancer	0.000231	0.000917	CcSEcCtD
Trabectedin—Headache—Etoposide—uterine cancer	0.00023	0.000912	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—uterine cancer	0.000228	0.000906	CcSEcCtD
Trabectedin—Syncope—Epirubicin—uterine cancer	0.000226	0.000896	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—uterine cancer	0.000225	0.000895	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—uterine cancer	0.000225	0.000895	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—uterine cancer	0.000221	0.000879	CcSEcCtD
Trabectedin—Cough—Epirubicin—uterine cancer	0.00022	0.000872	CcSEcCtD
Trabectedin—Nausea—Etoposide—uterine cancer	0.000218	0.000864	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—uterine cancer	0.000215	0.000855	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—uterine cancer	0.000214	0.000851	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—uterine cancer	0.000214	0.000851	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000213	0.000845	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—uterine cancer	0.000209	0.000829	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—uterine cancer	0.000208	0.000828	CcSEcCtD
Trabectedin—Oedema—Epirubicin—uterine cancer	0.000205	0.000816	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—uterine cancer	0.000205	0.000813	CcSEcCtD
Trabectedin—Infection—Epirubicin—uterine cancer	0.000204	0.000811	CcSEcCtD
Trabectedin—Cough—Doxorubicin—uterine cancer	0.000203	0.000807	CcSEcCtD
Trabectedin—Shock—Epirubicin—uterine cancer	0.000202	0.000803	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—uterine cancer	0.000201	0.0008	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—uterine cancer	0.000201	0.000799	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—uterine cancer	0.0002	0.000792	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—uterine cancer	0.000198	0.000787	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—uterine cancer	0.000198	0.000787	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000197	0.000782	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—uterine cancer	0.000196	0.000778	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—uterine cancer	0.000192	0.000762	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—uterine cancer	0.00019	0.000755	CcSEcCtD
Trabectedin—Infection—Doxorubicin—uterine cancer	0.000189	0.00075	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000187	0.000743	CcSEcCtD
Trabectedin—Shock—Doxorubicin—uterine cancer	0.000187	0.000743	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—uterine cancer	0.000186	0.00074	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000186	0.000739	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—uterine cancer	0.000186	0.000738	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—uterine cancer	0.000185	0.000733	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—uterine cancer	0.000184	0.000733	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—uterine cancer	0.000183	0.000727	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—uterine cancer	0.000181	0.00072	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—uterine cancer	0.000181	0.000718	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—uterine cancer	0.000179	0.000709	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—uterine cancer	0.000178	0.000705	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000177	0.000704	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—uterine cancer	0.000177	0.000703	CcSEcCtD
Trabectedin—Constipation—Epirubicin—uterine cancer	0.000176	0.000698	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000173	0.000688	CcSEcCtD
Trabectedin—Insomnia—Doxorubicin—uterine cancer	0.000172	0.000683	CcSEcCtD
Trabectedin—Paraesthesia—Doxorubicin—uterine cancer	0.000171	0.000678	CcSEcCtD
Trabectedin—Dyspnoea—Doxorubicin—uterine cancer	0.000169	0.000673	CcSEcCtD
Trabectedin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000168	0.000667	CcSEcCtD
Trabectedin—Dyspepsia—Doxorubicin—uterine cancer	0.000167	0.000664	CcSEcCtD
Trabectedin—Decreased appetite—Doxorubicin—uterine cancer	0.000165	0.000656	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000164	0.000652	CcSEcCtD
Trabectedin—Fatigue—Doxorubicin—uterine cancer	0.000164	0.000651	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—uterine cancer	0.000163	0.000646	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—uterine cancer	0.000162	0.000645	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—uterine cancer	0.000162	0.000645	CcSEcCtD
Trabectedin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000155	0.000617	CcSEcCtD
Trabectedin—Hypersensitivity—Epirubicin—uterine cancer	0.000151	0.000601	CcSEcCtD
Trabectedin—Abdominal pain—Doxorubicin—uterine cancer	0.00015	0.000597	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—uterine cancer	0.00015	0.000597	CcSEcCtD
Trabectedin—Asthenia—Epirubicin—uterine cancer	0.000147	0.000585	CcSEcCtD
Trabectedin—Diarrhoea—Epirubicin—uterine cancer	0.000141	0.000558	CcSEcCtD
Trabectedin—Hypersensitivity—Doxorubicin—uterine cancer	0.00014	0.000556	CcSEcCtD
Trabectedin—Asthenia—Doxorubicin—uterine cancer	0.000136	0.000542	CcSEcCtD
Trabectedin—Dizziness—Epirubicin—uterine cancer	0.000136	0.000539	CcSEcCtD
Trabectedin—Vomiting—Epirubicin—uterine cancer	0.000131	0.000519	CcSEcCtD
Trabectedin—Diarrhoea—Doxorubicin—uterine cancer	0.00013	0.000516	CcSEcCtD
Trabectedin—Rash—Epirubicin—uterine cancer	0.00013	0.000514	CcSEcCtD
Trabectedin—Dermatitis—Epirubicin—uterine cancer	0.000129	0.000514	CcSEcCtD
Trabectedin—Headache—Epirubicin—uterine cancer	0.000129	0.000511	CcSEcCtD
Trabectedin—Dizziness—Doxorubicin—uterine cancer	0.000126	0.000499	CcSEcCtD
Trabectedin—Nausea—Epirubicin—uterine cancer	0.000122	0.000485	CcSEcCtD
Trabectedin—Vomiting—Doxorubicin—uterine cancer	0.000121	0.00048	CcSEcCtD
Trabectedin—Rash—Doxorubicin—uterine cancer	0.00012	0.000476	CcSEcCtD
Trabectedin—Dermatitis—Doxorubicin—uterine cancer	0.00012	0.000476	CcSEcCtD
Trabectedin—Headache—Doxorubicin—uterine cancer	0.000119	0.000473	CcSEcCtD
Trabectedin—Nausea—Doxorubicin—uterine cancer	0.000113	0.000448	CcSEcCtD
Trabectedin—CYP2D6—Metabolism—SRD5A2—uterine cancer	5.89e-05	0.000489	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.87e-05	0.000488	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—AKT1—uterine cancer	5.85e-05	0.000486	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SRD5A2—uterine cancer	5.84e-05	0.000485	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NDUFB11—uterine cancer	5.84e-05	0.000485	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—FGFR2—uterine cancer	5.83e-05	0.000484	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—ERBB2—uterine cancer	5.81e-05	0.000482	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	5.8e-05	0.000482	CbGpPWpGaD
Trabectedin—SRC—Disease—DCN—uterine cancer	5.79e-05	0.000481	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RNF43—uterine cancer	5.69e-05	0.000473	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.67e-05	0.000471	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MET—uterine cancer	5.67e-05	0.000471	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—PIK3CA—uterine cancer	5.67e-05	0.000471	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—HRAS—uterine cancer	5.65e-05	0.00047	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—HRAS—uterine cancer	5.63e-05	0.000467	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—HRAS—uterine cancer	5.63e-05	0.000467	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—PIK3CA—uterine cancer	5.62e-05	0.000466	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—HRAS—uterine cancer	5.6e-05	0.000465	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—FGFR2—uterine cancer	5.6e-05	0.000465	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—PIK3CA—uterine cancer	5.57e-05	0.000462	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—AKT1—uterine cancer	5.55e-05	0.000461	CbGpPWpGaD
Trabectedin—SRC—Immune System—IRF1—uterine cancer	5.55e-05	0.000461	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—PIK3CA—uterine cancer	5.54e-05	0.00046	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PTEN—uterine cancer	5.47e-05	0.000454	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—KRAS—uterine cancer	5.46e-05	0.000454	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—AKT1—uterine cancer	5.46e-05	0.000453	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.36e-05	0.000445	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—PIK3CA—uterine cancer	5.35e-05	0.000445	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	5.33e-05	0.000443	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—RRM2—uterine cancer	5.25e-05	0.000436	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—HRAS—uterine cancer	5.24e-05	0.000435	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—INHBA—uterine cancer	5.21e-05	0.000432	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—HRAS—uterine cancer	5.2e-05	0.000432	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	5.16e-05	0.000428	CbGpPWpGaD
Trabectedin—SRC—Disease—AKR1C3—uterine cancer	5.15e-05	0.000428	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—HRAS—uterine cancer	5.15e-05	0.000428	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—HRAS—uterine cancer	5.13e-05	0.000426	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—DCN—uterine cancer	5.1e-05	0.000424	CbGpPWpGaD
Trabectedin—SRC—Disease—HMGA1—uterine cancer	5.02e-05	0.000417	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—PIK3CA—uterine cancer	5.02e-05	0.000417	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—AKT1—uterine cancer	4.99e-05	0.000415	CbGpPWpGaD
Trabectedin—SRC—Immune System—FBXW7—uterine cancer	4.97e-05	0.000413	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—AKT1—uterine cancer	4.97e-05	0.000413	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—AKT1—uterine cancer	4.97e-05	0.000413	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—HRAS—uterine cancer	4.95e-05	0.000411	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—AKT1—uterine cancer	4.94e-05	0.000411	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—NRAS—uterine cancer	4.88e-05	0.000405	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CYP11A1—uterine cancer	4.8e-05	0.000399	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	4.74e-05	0.000394	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—POLD1—uterine cancer	4.71e-05	0.000391	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKR1C1—uterine cancer	4.69e-05	0.000389	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	4.64e-05	0.000386	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—STAR—uterine cancer	4.63e-05	0.000385	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKR1B1—uterine cancer	4.63e-05	0.000385	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—AKT1—uterine cancer	4.63e-05	0.000384	CbGpPWpGaD
Trabectedin—SRC—Disease—FBXW7—uterine cancer	4.59e-05	0.000381	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—AKT1—uterine cancer	4.59e-05	0.000381	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.58e-05	0.00038	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—AKT1—uterine cancer	4.55e-05	0.000378	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKR1C3—uterine cancer	4.54e-05	0.000377	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—AKT1—uterine cancer	4.53e-05	0.000376	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—VEGFA—uterine cancer	4.47e-05	0.000372	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—NRAS—uterine cancer	4.42e-05	0.000367	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKR1C1—uterine cancer	4.4e-05	0.000366	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—AKT1—uterine cancer	4.37e-05	0.000363	CbGpPWpGaD
Trabectedin—SRC—Membrane Trafficking—AKT1—uterine cancer	4.37e-05	0.000363	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.36e-05	0.000362	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—STAR—uterine cancer	4.26e-05	0.000354	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKR1B1—uterine cancer	4.26e-05	0.000354	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKR1B1—uterine cancer	4.22e-05	0.000351	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—STAR—uterine cancer	4.22e-05	0.000351	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—KRAS—uterine cancer	4.2e-05	0.000349	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.17e-05	0.000347	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDH1—uterine cancer	4.16e-05	0.000346	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—ERBB2—uterine cancer	4.14e-05	0.000344	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	4.1e-05	0.000341	CbGpPWpGaD
Trabectedin—SRC—Immune System—SOCS3—uterine cancer	4.07e-05	0.000338	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—RRM2—uterine cancer	3.92e-05	0.000326	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—AKT1—uterine cancer	3.88e-05	0.000322	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PIK3CA—uterine cancer	3.86e-05	0.000321	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.85e-05	0.00032	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.85e-05	0.00032	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—DCN—uterine cancer	3.81e-05	0.000317	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—KRAS—uterine cancer	3.8e-05	0.000316	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—ERBB2—uterine cancer	3.66e-05	0.000304	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—POLD1—uterine cancer	3.63e-05	0.000302	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CTNNB1—uterine cancer	3.63e-05	0.000301	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKR1C3—uterine cancer	3.61e-05	0.0003	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN2B—uterine cancer	3.6e-05	0.000299	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP11A1—uterine cancer	3.59e-05	0.000298	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—uterine cancer	3.57e-05	0.000297	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—STK11—uterine cancer	3.53e-05	0.000294	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CYP19A1—uterine cancer	3.53e-05	0.000294	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PGR—uterine cancer	3.52e-05	0.000292	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ERBB2—uterine cancer	3.51e-05	0.000292	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKR1C1—uterine cancer	3.4e-05	0.000282	CbGpPWpGaD
Trabectedin—SRC—Immune System—FGFR2—uterine cancer	3.39e-05	0.000282	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKR1C3—uterine cancer	3.39e-05	0.000282	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CDKN1B—uterine cancer	3.39e-05	0.000282	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EP300—uterine cancer	3.37e-05	0.00028	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—YWHAE—uterine cancer	3.35e-05	0.000279	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—POLD1—uterine cancer	3.34e-05	0.000278	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.32e-05	0.000276	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—POLD1—uterine cancer	3.31e-05	0.000275	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—EP300—uterine cancer	3.31e-05	0.000275	CbGpPWpGaD
Trabectedin—SRC—Disease—SMAD3—uterine cancer	3.29e-05	0.000273	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDKN1B—uterine cancer	3.25e-05	0.00027	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—uterine cancer	3.23e-05	0.000268	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FBXW7—uterine cancer	3.22e-05	0.000267	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CTNNB1—uterine cancer	3.2e-05	0.000266	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—VEGFA—uterine cancer	3.19e-05	0.000265	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.16e-05	0.000263	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—AKT1—uterine cancer	3.15e-05	0.000262	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NRAS—uterine cancer	3.15e-05	0.000262	CbGpPWpGaD
Trabectedin—SRC—Disease—FGFR2—uterine cancer	3.13e-05	0.00026	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—VEGFA—uterine cancer	3.13e-05	0.00026	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKR1C1—uterine cancer	3.12e-05	0.00026	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PTEN—uterine cancer	3.12e-05	0.000259	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKR1C1—uterine cancer	3.1e-05	0.000257	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NRAS—uterine cancer	3.09e-05	0.000257	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—RRM2—uterine cancer	3.03e-05	0.000252	CbGpPWpGaD
Trabectedin—SRC—Disease—MTHFR—uterine cancer	3.02e-05	0.000251	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PTEN—uterine cancer	3e-05	0.000249	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EP300—uterine cancer	2.98e-05	0.000247	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—DCN—uterine cancer	2.94e-05	0.000244	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STK11—uterine cancer	2.81e-05	0.000234	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—RRM2—uterine cancer	2.79e-05	0.000231	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NRAS—uterine cancer	2.78e-05	0.000231	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—STAR—uterine cancer	2.78e-05	0.000231	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.78e-05	0.000231	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP11A1—uterine cancer	2.77e-05	0.00023	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—RRM2—uterine cancer	2.76e-05	0.000229	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—KRAS—uterine cancer	2.71e-05	0.000225	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—DCN—uterine cancer	2.7e-05	0.000225	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—DCN—uterine cancer	2.68e-05	0.000223	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NRAS—uterine cancer	2.67e-05	0.000222	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—KRAS—uterine cancer	2.66e-05	0.000221	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—MTHFR—uterine cancer	2.66e-05	0.000221	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—STK11—uterine cancer	2.64e-05	0.000219	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP19A1—uterine cancer	2.64e-05	0.000219	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SOCS3—uterine cancer	2.63e-05	0.000219	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKR1C3—uterine cancer	2.62e-05	0.000217	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP11A1—uterine cancer	2.55e-05	0.000212	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDH1—uterine cancer	2.53e-05	0.00021	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.53e-05	0.00021	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN2B—uterine cancer	2.52e-05	0.000209	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IGF1R—uterine cancer	2.45e-05	0.000203	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PIK3CA—uterine cancer	2.45e-05	0.000203	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKR1C3—uterine cancer	2.41e-05	0.0002	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KRAS—uterine cancer	2.4e-05	0.000199	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.38e-05	0.000198	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—uterine cancer	2.37e-05	0.000197	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.34e-05	0.000194	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—uterine cancer	2.31e-05	0.000192	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KRAS—uterine cancer	2.3e-05	0.000191	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SMAD3—uterine cancer	2.3e-05	0.000191	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—uterine cancer	2.26e-05	0.000188	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PIK3CA—uterine cancer	2.2e-05	0.000183	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FGFR2—uterine cancer	2.19e-05	0.000182	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—POLD1—uterine cancer	2.18e-05	0.000181	CbGpPWpGaD
Trabectedin—SRC—Immune System—ERBB2—uterine cancer	2.13e-05	0.000177	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CA—uterine cancer	2.11e-05	0.000176	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.04e-05	0.00017	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—STK11—uterine cancer	2.04e-05	0.000169	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP19A1—uterine cancer	2.04e-05	0.000169	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—uterine cancer	2.04e-05	0.000169	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—uterine cancer	2.04e-05	0.000169	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—uterine cancer	2e-05	0.000166	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—MTHFR—uterine cancer	1.98e-05	0.000165	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1B—uterine cancer	1.97e-05	0.000164	CbGpPWpGaD
Trabectedin—SRC—Disease—ERBB2—uterine cancer	1.97e-05	0.000163	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—uterine cancer	1.96e-05	0.000162	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.91e-05	0.000159	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ESR1—uterine cancer	1.88e-05	0.000156	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—STK11—uterine cancer	1.87e-05	0.000156	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.87e-05	0.000156	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTNNB1—uterine cancer	1.86e-05	0.000155	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—STK11—uterine cancer	1.86e-05	0.000154	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.86e-05	0.000154	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.82e-05	0.000152	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1B—uterine cancer	1.82e-05	0.000151	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—RRM2—uterine cancer	1.82e-05	0.000151	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTEN—uterine cancer	1.82e-05	0.000151	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—uterine cancer	1.8e-05	0.000149	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—DCN—uterine cancer	1.77e-05	0.000147	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.74e-05	0.000145	CbGpPWpGaD
Trabectedin—SRC—Immune System—EP300—uterine cancer	1.73e-05	0.000144	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—uterine cancer	1.73e-05	0.000143	CbGpPWpGaD
Trabectedin—SRC—Disease—CTNNB1—uterine cancer	1.72e-05	0.000143	CbGpPWpGaD
Trabectedin—SRC—Disease—PTEN—uterine cancer	1.68e-05	0.000139	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.67e-05	0.000138	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.66e-05	0.000138	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCL2—uterine cancer	1.65e-05	0.000137	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRAS—uterine cancer	1.62e-05	0.000135	CbGpPWpGaD
Trabectedin—SRC—Disease—EP300—uterine cancer	1.6e-05	0.000133	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.57e-05	0.000131	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—MTHFR—uterine cancer	1.53e-05	0.000127	CbGpPWpGaD
Trabectedin—SRC—Disease—NRAS—uterine cancer	1.5e-05	0.000124	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTEN—uterine cancer	1.48e-05	0.000123	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—EP300—uterine cancer	1.41e-05	0.000117	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—MTHFR—uterine cancer	1.41e-05	0.000117	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—MTHFR—uterine cancer	1.4e-05	0.000116	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—uterine cancer	1.4e-05	0.000116	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB2—uterine cancer	1.38e-05	0.000114	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.35e-05	0.000112	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL8—uterine cancer	1.31e-05	0.000109	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—uterine cancer	1.29e-05	0.000107	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CA—uterine cancer	1.28e-05	0.000107	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1B—uterine cancer	1.28e-05	0.000106	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.23e-05	0.000102	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.23e-05	0.000102	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—STK11—uterine cancer	1.23e-05	0.000102	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNB1—uterine cancer	1.21e-05	0.0001	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—uterine cancer	1.19e-05	9.85e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CA—uterine cancer	1.18e-05	9.83e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTEN—uterine cancer	1.18e-05	9.76e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EP300—uterine cancer	1.12e-05	9.31e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTEN—uterine cancer	1.1e-05	9.17e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—uterine cancer	1.1e-05	9.1e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—uterine cancer	1.06e-05	8.82e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—EP300—uterine cancer	1.05e-05	8.75e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRAS—uterine cancer	1.05e-05	8.71e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—uterine cancer	1.05e-05	8.7e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CA—uterine cancer	1.04e-05	8.66e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—uterine cancer	9.67e-06	8.03e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MTHFR—uterine cancer	9.21e-06	7.65e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—uterine cancer	9.02e-06	7.5e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTEN—uterine cancer	8.52e-06	7.08e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—uterine cancer	8.51e-06	7.07e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CA—uterine cancer	8.29e-06	6.89e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—EP300—uterine cancer	8.12e-06	6.75e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—uterine cancer	8.02e-06	6.66e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTEN—uterine cancer	7.83e-06	6.51e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CA—uterine cancer	7.79e-06	6.47e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTEN—uterine cancer	7.77e-06	6.45e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—uterine cancer	7.67e-06	6.37e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—EP300—uterine cancer	7.47e-06	6.21e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—EP300—uterine cancer	7.41e-06	6.15e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—uterine cancer	6.77e-06	5.63e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—uterine cancer	6.36e-06	5.29e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CA—uterine cancer	6.01e-06	4.99e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CA—uterine cancer	5.53e-06	4.59e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CA—uterine cancer	5.48e-06	4.55e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTEN—uterine cancer	5.12e-06	4.26e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—uterine cancer	4.91e-06	4.08e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—EP300—uterine cancer	4.89e-06	4.06e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—uterine cancer	4.52e-06	3.75e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—uterine cancer	4.48e-06	3.72e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.61e-06	3e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—uterine cancer	2.95e-06	2.45e-05	CbGpPWpGaD
